Advertisement

The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.

This Forum is made possible in part by Gilead and GlaxoSmithKline.

Ask the Experts about Choosing Your Meds
Recent AnswersAsk a Question

 

Sequencing
May 21, 2005

Dear Doctor,

My labs are the following: CD4 178; VL >100,000. My doctor began my regimen with Dapsone, I could not tolerate Bactrim. The antiretrovirals are Sustiva+Epzicom. What are your thoughts on this regimen? How soon should I expect failure/resistance on this regimen? If this is the case, what other future options could I probably have in the future? I will appreciate any respond. Thanks for all the work you do in this great website.

Response from Dr. Young

Thanks for your post.

Assuming that you continue to take your medications faithfully and you didn't acquire drug resistant virus, the combination of Epzicom and Sustiva should work very well.

In the CNA30021 and CNA30024 clinical studies, about 70% of patients never had a viral load greater than 50 copies after one year of treatment. Among the ~10% with viral failures, drug resistance mutations were only seen in about half (or ~5% of patients). Many of these patients had baseline drug resistance, emphasizing the importance of getting drug resistance testing before starting on treatment.

The kind of resistance seen among these patients is the key part of the preservation of future treatment option question. Most of these patients developed resistance to efavirenz (Sustiva) and 3TC (half of Epzicom). Additional resistance to abacavir was very rarely seen. Hence, patients who had the emergence of drug resistance were likely to compromise the use of future NNRTIs and some NRTIs, but should have quite a few future options, including the thymidine nukes, tenofovir and all protease inhibitors.

I hope this helps to clarify your question. Feel free to write back with any additional concerns.

Good luck, keep up the adherence. BY



Terms of Use
Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.

Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their messages.

Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a health or legal problem, you should consult your own health care provider or your attorney.

Copyright notice.

Advertisement